Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Design Therapeutics (DSGN) Income from Continuing Operations: 2020

Historic Income from Continuing Operations for Design Therapeutics (DSGN) over the last 1 years, with Dec 2020 value amounting to -$3.9 million.

  • Design Therapeutics' Income from Continuing Operations was N/A to -$3.9 million in Q4 2020 from the same period last year, while for Dec 2020 it was -$8.3 million, marking a year-over-year change of. This contributed to the annual value of -$8.3 million for FY2020, which is N/A change from last year.
  • Latest data reveals that Design Therapeutics reported Income from Continuing Operations of -$3.9 million as of Q4 2020, which was down 62.02% from -$2.4 million recorded in Q3 2020.
  • Design Therapeutics' Income from Continuing Operations' 5-year high stood at -$623,000 during Q1 2020, with a 5-year trough of -$3.9 million in Q4 2020.
  • Over the past 1 years, Design Therapeutics' median Income from Continuing Operations value was -$1.9 million (recorded in 2020), while the average stood at -$2.1 million.